AIM
NEO icon

Acrospire Investment Management’s NeoGenomics NEO Stock Holding History

Acrospire Investment Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-3,475
Closed -$27K – 2413
2017
Q1 		$27K Sell
3,475
-2,532
-42% -$20.6K 0.02% 1423
2016
Q4 		$51K Sell
6,007
-134
-2% -$1.15K 0.02% 1388
2016
Q3 		$50K Sell
6,141
-3,800
-38% -$31.9K 0.03% 1068
2016
Q2 		$80K Buy
9,941
+2,601
+35% +$20.8K 0.06% 654
2016
Q1 		$49K Buy
+7,340
New +$48.3K 0.03% 972

Other funds holding NEO

GE
General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return
CPA
Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

Acrospire Investment Management's NEO Position: Q2 2017 in Review

Acrospire Investment Management sold out of NeoGenomics (NEO) in Q2 2017, closing a stake of 3,475 shares — an estimated $27K sold.

Acrospire Investment Management first reported a position in NEO in Q1 2016 and held it in 5 quarters. The position peaked at $80K in Q2 2016. 134 funds tracked by Wall St. Rank hold NEO as of Q2 2017.

  • Acrospire Investment Management reported no remaining NeoGenomics position as of Q2 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 3,475 NeoGenomics shares in Q2 2017, an estimated $27K.
  • Acrospire Investment Management first reported a position in NeoGenomics in Q1 2016 and held it in 5 quarters.
  • Acrospire Investment Management's NeoGenomics position peaked at $80K in Q2 2016.
  • 134 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2017.

Based on Acrospire Investment Management's 13F filing for Q2 2017, filed 11 Aug 2017.